Author

Michel Roberge

University of British ColumbiaORCID 0000-0002-2100-0793Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Michel Roberge1 paper

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Hirofumi KaiiD· 1 shared Jeffrey H. MineriD· 1 shared Kohei OmachiiD· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

3 top collaborators · 3 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetics

Hirofumi KaiORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

GeneticsbioRxivPreprintJun 11, 2021

Aminoglycoside-induced premature termination codon readthrough of COL4A5 nonsense mutations that cause Alport syndrome

Kohei Omachi, Hirofumi Kai, Michel Roberge, Jeffrey H. Miner

This study investigates the feasibility of PTC readthrough therapy for Alport syndrome by testing its effect on COL4A5 nonsense mutations using a luciferase reporter system.

3 citations

humanexperimental assay

𝕏 PostBluesky